Picture Consultech GmbH Secure Funding with RnD Grants v7 650x100px

Persons > All

Find below all kinds of persons.

Total search results: 8775 | Ordered by Person (ascending)
next pagenext page 1 2 3 ... 86 87 88  next pagenext page

order ascendingorder descendingPerson order ascendingorder descendingPosition order ascendingorder descendingOrganisation (Group) order ascendingorder descendingCountry
Yap, Richard (Numares 201612– Managing Director of Numares Singapore before Avdisor + OrbusNeich) Managing Director Numares (Group) Singapore
Yaspo, Marie-Laure n. a. Source BioScience (Group) Germany
Yates, Robert (Merck (DE) 201109–201493 President of Merck Millipore before Roche Diagnostics LEFT 3/14) President/Director/Head Business Group/Unit/Division Merck (DE) (Group) United States (USA)
Yeager, Frank (Eckert & Ziegler 202305– promoted to Management Board Director for Isotope Products) Board member, executive Eckert & Ziegler (Group) Germany
Yee, Sidney (Singapore (govt) 201510 CEO of DxD Hub of A*STAR) Chief Executive Officer (CEO) Singapore (govt) Singapore
Yemm, Stephen (Steve) (Optibrium 202301– Chief Commercial Officer before Paradigm4 + Aigenpulse + BioData + Vialis) Chief Commercial Officer (CCO) Optibrium (Group) United Kingdom (GB)
Yerganian, Syrane (Strammer 201704 CFO) Chief Executive Officer (CEO) Strammer (Group) France
Yianni, John (CryoTherapeutics GmbH 201305 Managing Director) Managing Director CryoTherapeutics GmbH Germany
Yildiz, Marius (Murat) (Avergen Pharmaceuticals GmbH 201510– Managing Director) Managing Director Avergen Pharmaceuticals GmbH (APG) Germany
Ylisaukko-oja, Tero (MedEngine Oy 201901 CEO) Chief Executive Officer (CEO)
Yoder, Stephen S. (Steve) (Pieris 201001– CEO before MorphoSys Head Licensing + IP) Chief Executive Officer (CEO) Pieris (Group) Germany
Yoo, Stephen (Anjarium Biosciences 202206– CEO before Third Harmonic Bio + Regenxbio + MedImmune + Abbott Labs) Chief Executive Officer (CEO) Anjarium Biosciences AG Switzerland
York, Gwill (Lighthouse Capital Partners 202110 Founding Managing Director) Managing Director Lighthouse Capital Partners (US) United States (USA)
Yoshitaka, Shinsuke (Denka 201508 President + CEO) Chief Executive Officer (CEO) Denka (Group) Japan
Young, Diane (Novartis Oncology 200601) n. a. Novartis (Group) Switzerland
Young, Jordan (Repare Therapeutics 202305 Director of SNIPRx platform) n. a.
Young, Joshua (Bruker 201301– VP Investor Relations before Merck KGA + Millipore LEFT BEFORE 7/16) Public Relations Manager / Investor Relations Manager Bruker (Group) United States (USA)
Yousaf, Shaf (Sigma-Aldrich 201412 VP Tech + BusDev before Life Technologies + Applied Biosystems + Sigma-Aldrich) President/Director/Head Business Group/Unit/Division Thermo Fisher (Group) United States (USA)
Yrjänheikki, Juha (Aurealis Pharma 201708 CEO) Chief Executive Officer (CEO) Aurealis Therapeutics AG Switzerland
Yu, Chen (TCG Crossover 202107 Managing Partner + Founder before Vivo Capital 201504 Managing Partner) Managing Partner (investment firm) Column Group LLC, The (TCG) United States (USA)
Yu, Frank (Ally Bridge Group 201702 CEO + CIO + Founder) Chief Executive Officer (CEO) Ally Bridge Group (ABG) China
Yu, Guo-Liang (Epitomics 201105 CEO) Chief Executive Officer (CEO) Abcam (Group) United States (USA)
Yule, Murray (iOmx Therapeutics 202202– CMO before MorphoSys) Chief Medical Officer (CMO) iOmx Therapeutics AG Germany
Yusibov, Vidadi (Fraunhofer USA 201009 Exec Director CMB + iBio 201009 CSO) Researcher (university / research institute) Fraunhofer (Group) United States (USA)
Yver, Antoine (AstraZeneca 201309 VP + Head of Oncology in Global Medicines Development Unit) President/Director/Head Business Group/Unit/Division AstraZeneca (Group) United Kingdom (GB)
Yzer, Cornelia (Berlin (govt) 201305 Senator of Economy, Technology, and Research) Minister Berlin (govt region) Germany
Yönel, Mutlu (Prosion 202308 Managing Director (CFO) + Co-Founder) Chief Financial Officer (CFO) Prosion GmbH (Prosion Therapeutics) Germany
Zabel, Nina (BioRegio STERN 201802–) Cluster Manager BioRegio STERN Management GmbH Germany
Zabrowski, Dan (Roche 201202– Head Roche Applied Science before Roche Global Head Pharma Partnering) President/Director/Head Business Group/Unit/Division Roche (Group) United States (USA)
Zaby, Andreas (Curacyte 200601) n. a. Curacyte (Group) Germany
Zacharias, Dietmar (Hochschule Bremen 201303 Professor for Applied + Ecological Botanics) Professor University of Applied Sciences Bremen (Hochschule Bremen) Germany
Zachert, Matthias (Lanxess 201401– CEO before Merck (DE) CFO) Chief Executive Officer (CEO) Lanxess (Group) Germany
Zachmann, Julian (Strüngmann Group 202308 Investment Manager before HTGF) Investment Manager STRÜNGMANN Group (family Strüngmann) Germany
Zafirakos, Elias (BioPeople (DK) 201404 Science Liaison Officer) Cluster Manager Biopeople (Denmark’s Life Science Cluster) Denmark
Zahn, Dorothea (BST Bio Sensor Technology GmbH 201110 Managing Director) Managing Director BST Bio Sensor Technologie GmbH Germany
Zahn, Grit (Eternygen GmbH 201309– Head of Research before ipal GmbH + Jerini) Research & Development Manager Eternygen (Group) Germany
Zahn, Ralph (Priavoid 201709– Co-Founder formerly Biocrates 201306 CTO) Chief Technology/Technical Officer (CTO) Priavoid GmbH Germany
Zahnd, Christian (Molecular Partners 200708 CEO RESIGNED 11/16) Chief Executive Officer (CEO) Molecular Partners AG (SIX: MOLN, Nasdaq: MOLN) Switzerland
Zaimenko, Inna (Versatile Biology Lab 202210 Founder) Company Founder Versatile Biology Lab (Inna Zaimenko) Germany
Zambon, Elena (Zambon 201907 President) Board member Zambon (Group) Italy
Zamboni, Nicola (ETH Zurich 201007 Institute of Molecular Systems Biology) Researcher (university / research institute) ETH Zürich (ETHZ) Switzerland
Zampieri, Gianni (Galenica Group 201702 CEO of Vifor Pharma) Chief Executive Officer (CEO) Vifor Pharma (Group) Switzerland
Zanchi, Marta-Gaia (Nina Capital 202011 Founder + Managing Partner) Partner (venture partner) Nina Capital SGEIC S.A. Spain (España)
Zang, Jingwu (I-Mab 201711 CEO + Founder of I-Mab Biopharma before GSK RnD China 200705 Head) Chief Executive Officer (CEO) GSK (Group) United Kingdom (GB)
Zanzinger, Johannnes (Boehringer 202001 at BIVF) Investment Manager Boehringer Ingelheim Venture Fund (BIVF) Germany
Zapico, David A. (AMETEK 201608 CEO) Chief Executive Officer (CEO) AMETEK (Group) United States (USA)
Zarrehparvar, Mazi (MicrobeDx 201701 CEO) Chief Executive Officer (CEO) MicrobeDx (Group) United States (USA)
Zauderer, Maurice (Vaccinex 200803 CEO) Chief Executive Officer (CEO) Vaccinex Inc. United States (USA)
Zazulina, Victoria (Merck (DE) 202209 Head of Development Unit Oncology before Boehringer Ingelheim) President/Director/Head Business Group/Unit/Division Merck (DE) (Group) Germany
Zbar, Brett (General Atlantic 202009– Managing Director + Global Head Life Sciences before Foresite Capital + Aisling) Managing Director General Atlantic (Group) United States (USA)
Zbinden, Laurent (MedXCell 202203 CEO) Chief Executive Officer (CEO) MedXCell (Group) Switzerland
Zech, Birgit (Anavo Therapeutics 202104 CEO before Gotham Therapeutics + X-Rx + MAB Discovery + Pieris + Axxima) Chief Executive Officer (CEO) Anavo Therapeutics (Group) Netherlands
Zechner, Rudolf (Univ Graz 201308 Professor at Instittue for Molecular Biosciences) Professor University of Graz (Karl-Franzens-Universität) Austria
Zeh, Alexander (Tacalyx 202205 Head of Finance + Administration) Chief Financial Officer (CFO) Tacalyx GmbH Germany
Zehethofer, Karl n. a. Greiner (Group) Austria
Zehetmayer, Peter (Acquifer Imaging 202301 COO + Director for Sales + Marketing) Chief Operating Officer (COO) Bruker (Group) Germany
Zehnder, Alexander (CureVac 202304– CEO before Sanofi + Roche/Genetech) Chief Executive Officer (CEO) CureVac (Group) Germany
Zehntner, Heiner (Endress+Hauser 201309 Member of Executive Board) Board member, executive Endress+Hauser (Group) Switzerland
Zeidler, Reinhard (Helmholtz 201801 Prof Gene Vectors Research Unit at Helmholtz Zentrum München) Professor Helmholtz-Gemeinschaft (HGF) (Group) Germany
Zeinali, Sirous (Genetek Biopharma 201805 Managing Director + Co-Founder) Managing Director Genetek Biopharma GmbH Germany
Zeise, Antje (Epigenomics 201112 Manager IR | PR) Public Relations Manager / Investor Relations Manager Epigenomics (Group) Germany
Zell, Andreas n. a. University of Tübingen (Eberhard-Karls-Universität) Germany
Zeller, Marco (VC Fonds Berlin 200508 Managing Director) Managing Director Berlin (govt region) Germany
Zeltner, Jürg (UBS 201604 President of UBS Wealth Management) President/Director/Head Business Group/Unit/Division UBS (Group) Switzerland
Zeltz, Patric (BadenBioTec 201104 Managing Director before BF-Biolabs 200312– founder) Managing Director BadenBioTec GmbH Germany
Zencke, Peter (MeVis Medical Solutions 200708–201106 Supervisory Board Member) Supervisory Board Member Varian Medical Systems (Group) Germany
Zenker, Matthias (GAIA 201702 Business Development) Business Development Manager / Strategy Manager GAIA AG Germany
Zenker, Othmar (InflaRx 201706– CMO before Head Clinical Research + Development since 2013 before CSL Behring) Research & Development Manager InflaRx (Group) Germany
Zenobi, Renato (ETH Zürich 201006 Professor Dept of Chemistry) Professor ETH Zürich (ETHZ) Switzerland
Zentgraf, Martin (Desitin 201202 General Manager of Desitin Arzneimittel GmbH) General Manager (management) Desitin Arzneimittel GmbH Germany
Zepp, Tobias (CRS Clinical Research Services 201706 Corporate Communications Manager) Public Relations Manager / Investor Relations Manager CRS Clinical Research Services (Group) Germany
Zerhouni, Elias A. (Sanofi-Aventis 201101– President Global RnD before NIH Director 2002–2008) Research & Development Manager Sanofi (Group) [since May 2011] France
Zerrer, Ralf (Clariant 201801 Head Strategic Marketing + Innovation at Business Unit Industrial + Consumer Specialties) Sales Manager / Marketing Manager Clariant (Group) Switzerland
Zettl, Rolf (Combinature co-founder + CEO 200011–200504 afterwards CBO) Chief Business Officer (CBO) MerLion (Group) Germany
Zettl, Rolf (Helmholtz 201502 Managing Director) Managing Director Helmholtz-Gemeinschaft (HGF) (Group) Germany
Zettl, Sophie (CEBINA 202003 before Arsanis + MedImmune/AZ) Business Development Manager / Strategy Manager CEBINA GmbH (Central European Biotech Incubator and Accelerator) Austria
Zettlmeissl, Gerd (Intercell 2005–201105 CEO before COO since 2001 before Chiron Behring before Behringwerke) Chief Executive Officer (CEO) Valneva (Group) Austria
Zetzmann-Krien, Diane (Bremen (govt) 201110 Managing Director of Bremer Aubau-Bank GmbH) Managing Director Bremen (govt region) Germany
Zeyer, Denis (Novalix 201011 CEO) Chief Executive Officer (CEO) Novalix (Group) France
Zeyfang, D. n. a. DaimlerChrylser (Group) Germany
Zhang, Ingrid (Novartis 201904 President Novartis Pharmaceuticals China) President/Director/Head Business Group/Unit/Division Novartis (Group) China
Zhang, Jay Z. (Shuwen Biotech 201512 CEO) Chief Executive Officer (CEO) Shuwen Biotech Co. Ltd. China
Zhang, Lei (Univ Bremen 200603) n. a. University of Bremen Germany
Zhang, Peizhuo (Qiagen 201305– General Manager of Qiagen (Suzhou) Translational Medical Center) General Manager (management) Qiagen (Group) China
Zhang, Weiyi (Boehringer 202007 Head of External Innovation Hub China) President/Director/Head Business Group/Unit/Division Boehringer Ingelheim (Group) China
Zhang, Zeeman (Beijing Clear Biotech 201509 Director) President/Director/Head Business Group/Unit/Division Beijing Clear Biotech Co., Ltd. (BCB) China
Zhao, Xing (ReLive 202301 CEO + Founder) Chief Executive Officer (CEO) ReLive (Group)
Zheng, Li-Mou (Amoy Diagnostics 201607 CEO) Chief Executive Officer (CEO) Amoy Diagnostics Co., Ltd. (AmoyDx) China
Zhou, Frank (Grand Pharmaceutical 202112 CEO) Chief Executive Officer (CEO) Grand Pharmaceutical Group Ltd. (Grand Pharma, GP) China
Zhou, Jack (B&W Tek LLC 201807 CEO) Chief Executive Officer (CEO) Metrohm (Group) United States (USA)
Zhou, Li (TxCell 201610– VP Cell Engineerung before ZMKS + Novartis Biologics Center MA + MGH + Cereon Genomics) Researcher (industry) TxCell S.A. (Euronext Paris: TXCL) France
Zhou, WeiQing (LifeMine Therapeutics 202102 COO + Co-Founder + FogPharma COO + Co-Founder) Chief Operating Officer (COO) LifeMine Therapeutics (Group) United States (USA)
Zhu, John (DualityBio 202304 CEO + Founder formerly 6 Dimensions Capital) Chief Executive Officer (CEO)
Zhu, Ted (Fosun Group 201407 General Manager of Fosun Diagnostics division) General Manager (management) Fosun (Group) China
Zhukovsky, Eugene (Biomunex 201510– CSO before Affimed + Boehringer Ingelheim Pharmaceuticals + Xencor) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) Biomunex Pharmaceuticals SASU France
Zickgraf, Patrik (Ganzimmun Diagnostics 202112 CEO) Chief Executive Officer (CEO) Ganzimmun Diagnostcs AG (GD) Germany
Ziebig, Marlene (Gulde Hengelhaupt Ziebig & Schneider 200809 Berlin) n. a. Grünecker, Kinkeldey, Stockmair & Schwanhäusser GbR Germany
Ziebolz, Burkhard (Roche Diagnostics 200503) n. a. Roche (Group) Germany
Ziegelbauer, Karl (Almirall 202205 CSO) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) Almirall (Group) Spain (España)
Ziegenhagen, Andreas (Dentons 201412 Managing Partner Germany) Managing Partner Dentons (Group) Switzerland
next pagenext page 1 2 3 ... 86 87 88  next pagenext page


Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Berlin Partner Top News Ariceum Raises €47m for Radiopharma 650x300px

» top